The cancer antigenome
暂无分享,去创建一个
[1] J. Loutit,et al. Treatment of Murine Leukaemia with X Rays and Homologous Bone Marrow , 1956, British medical journal.
[2] M. Pike,et al. Somatic Mutation , 1965, British medical journal.
[3] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[4] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[5] J. Renauld,et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1994, The Journal of experimental medicine.
[6] K. Sakaguchi,et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Wharton,et al. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines , 1995, The Journal of experimental medicine.
[8] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[9] A. Viel,et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. , 1999, The American journal of pathology.
[10] Ferry Ossendorp,et al. Efficient Identification of Novel Hla-A*0201–Presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen Prame by Proteasome-Mediated Digestion Analysis , 2001, The Journal of experimental medicine.
[11] E. Schaftingen,et al. High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival. , 2001, Cancer research.
[12] M. Bertrand,et al. An overview of the MAGE gene family with the identification of all human members of the family. , 2001, Cancer research.
[13] S Brunak,et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. , 2003, Tissue antigens.
[14] G. Kalemkerian,et al. Small cell lung cancer , 2010, Seminars in Respiratory and Critical Care Medicine.
[15] T. Schumacher,et al. The Impact of Self-Tolerance on the Polyclonal CD8+ T Cell Repertoire1 , 2004, The Journal of Immunology.
[16] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[17] Masahiro Toda,et al. Identification of human tumor antigens and its implications for diagnosis and treatment of cancer , 2004, Cancer science.
[18] C. Huber,et al. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Steinberg,et al. Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma , 2005, The Journal of Immunology.
[20] S. Rosenberg,et al. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.
[21] Thierry Boon,et al. Human T cell responses against melanoma. , 2006, Annual review of immunology.
[22] T. Schumacher,et al. Design and use of conditional MHC class I ligands , 2006, Nature Medicine.
[23] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[24] T. Schumacher,et al. Generation of peptide–MHC class I complexes through UV-mediated ligand exchange , 2006, Nature Protocols.
[25] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[26] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[27] A. Billiau,et al. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect , 2007, Nature Clinical Practice Oncology.
[28] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[29] S. Rosenberg,et al. Adoptive cell transfer: a clinical path to effective cancer immunotherapy , 2008, Nature Reviews Cancer.
[30] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[31] Martin A. Nowak,et al. Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.
[32] Amy E. Hawkins,et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.
[33] T. Schumacher,et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 , 2008, Proceedings of the National Academy of Sciences.
[34] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[35] K. Kinzler,et al. Epitope landscape in breast and colorectal cancer. , 2008, Cancer research.
[36] S. Rosenberg,et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. , 2009, Blood.
[37] M. Stratton,et al. The cancer genome , 2009, Nature.
[38] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[39] Ton N Schumacher,et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers , 2009, Nature Methods.
[40] Evan W. Newell,et al. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining , 2009, Nature Methods.
[41] A. Sparks,et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient , 2010, Nature.
[42] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[43] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[44] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[45] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[46] S. Gabriel,et al. Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.
[47] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[48] H. Lehrach,et al. Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis , 2010, PloS one.
[49] S. Davis,et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma , 2011, Nature Genetics.
[50] Zev A. Binder,et al. The Genetic Landscape of the Childhood Cancer Medulloblastoma , 2011, Science.
[51] T. Schumacher,et al. An Early HIV Mutation within an HLA-B*57-Restricted T Cell Epitope Abrogates Binding to the Killer Inhibitory Receptor 3DL1 , 2011, Journal of Virology.
[52] M. Stratton. Exploring the Genomes of Cancer Cells: Progress and Promise , 2011, Science.
[53] Jianhua Zhao,et al. Advances in whole genome sequencing technology. , 2011, Current pharmaceutical biotechnology.
[54] Axel Hoos,et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. , 2011, The New England journal of medicine.
[55] Hidenori Ojima,et al. High-resolution characterization of a hepatocellular carcinoma genome , 2011, Nature Genetics.
[56] M. Raffeld,et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] Christopher D. Brown,et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data , 2011, Proceedings of the National Academy of Sciences.
[58] T. Schumacher,et al. Dissection of T-cell antigen specificity in human melanoma. , 2012, Cancer research.
[59] Richard Martin Bambury,et al. Intratumor heterogeneity and branched evolution. , 2012 .
[60] E. Mardis,et al. Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.
[61] J. Castle,et al. Exploiting the mutanome for tumor vaccination. , 2012, Cancer research.
[62] Ton N Schumacher,et al. Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers , 2012, Nature Protocols.
[63] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[64] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[65] C. Drake,et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.
[66] T. Schumacher,et al. TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients , 2012, Oncoimmunology.
[67] M. Stratton,et al. Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.